Cargando...
Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma
MYSM1 is a chromatin‐binding protein, widely investigated for its functions in haematopoiesis in human and mouse; however, its role in haematologic malignancies remains unexplored. Here, we investigate the cross‐talk between MYSM1 and oncogenic cMYC in the transcriptional regulation of genes encodin...
Guardado en:
| Publicado en: | J Cell Mol Med |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8278115/ https://ncbi.nlm.nih.gov/pubmed/34114734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16554 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|